Successful Treatment of Cardiac Haemangiomas with Oral Propranolol: a Case Series of Two Patients

Overview

Journal Eur Heart J Case Rep

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2019 Aug 27

PMID 31449646

Citations 5

Authors

Ioannis Polymerou

Tiina Ojala

Pipina Bonou

Laura Martelius

Aphrodite Tzifa

Affiliations

Soon will be listed here.

Abstract

Background: Cardiac haemangiomas are extremely rare tumours with equivocal surgical outcomes. Haemangiomas appearing on other sites of the body have been successfully treated with oral propranolol. To the best of our knowledge, such treatment has not been tried to date for cardiac location of haemangiomas.

Case Summary: We report two cases of neonatal cardiac haemangiomas, and we describe their presentation and characteristics, as well as how these were successfully treated with oral propranolol, with complete regression of the tumours within the 1st year of life.

Discussion: Despite the rarity of cardiac haemangiomas, their presentation and complications could be dramatic with side-effects spanning from intracardiac space occupying phenomena to Kasabach-Merritt syndrome. Propranolol therapy, having been established for long now in the treatment of skin haemangiomas, should also be considered in cases of cardiac haemangiomas, particularly in the neonatal and infantile population.

Citing Articles

Advanced presentation of cardiac hemangioma.

Rattenni F, Arlati F, Galanti A, Sansone F, Clerici A, Triggiani M J Cardiothorac Surg. 2024; 19(1):620.

PMID: 39497164 PMC: 11533277. DOI: 10.1186/s13019-024-02984-5.

Right ventricular outflow tract obstruction by cardiac hemangioma in asymptomatic patient.

Kaewboonlert N, Chunharas P, Pluthikarmpae N, Poontananggul J, Wongthep A, Pongsuwan N J Surg Case Rep. 2024; 2024(5):rjae321.

PMID: 38764738 PMC: 11102782. DOI: 10.1093/jscr/rjae321.

Cardiac hemangioma in the atrioventricular node localization.

Batko J, Rams D, Bartus K, Bartoszcze A, Litwinowicz R Kardiochir Torakochirurgia Pol. 2023; 20(1):57-59.

PMID: 37077459 PMC: 10107410. DOI: 10.5114/kitp.2023.126102.

Right ventricular haemangioma as a rare cause of chest pain: a case report.

Tang M, Jian Z, Yan Y, Guo F Eur Heart J Case Rep. 2022; 5(12):ytab477.

PMID: 35047734 PMC: 8759472. DOI: 10.1093/ehjcr/ytab477.

What Is Hidden Behind Inferior Negative T Waves: Multiple Cardiac Glomangiomas.

Castiglione V, Aimo A, Murzi B, Pucci A, Aquaro G, Barison A JACC Case Rep. 2021; 1(4):657-662.

PMID: 34316900 PMC: 8288779. DOI: 10.1016/j.jaccas.2019.10.007.

References

Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo J, Taieb A . Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008; 358(24):2649-51. DOI: 10.1056/NEJMc0708819. View

Kelly M . Kasabach-Merritt phenomenon. Pediatr Clin North Am. 2010; 57(5):1085-9. DOI: 10.1016/j.pcl.2010.07.006. View

Beroukhim R, Prakash A, Valsangiacomo Buechel E, Cava J, Dorfman A, Festa P . Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011; 58(10):1044-54. DOI: 10.1016/j.jacc.2011.05.027. View

Padalino M, Vida V, Boccuzzo G, Tonello M, Sarris G, Berggren H . Surgery for primary cardiac tumors in children: early and late results in a multicenter European Congenital Heart Surgeons Association study. Circulation. 2012; 126(1):22-30. DOI: 10.1161/CIRCULATIONAHA.111.037226. View

McAllister Jr H . Primary tumors of the heart and pericardium. Pathol Annu. 1979; 14 Pt 2:325-55. View

Munden A, Butschek R, Tom W, Marshall J, Poeltler D, Krohne S . Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014; 170(4):907-13. PMC: 4410180. DOI: 10.1111/bjd.12804. View

Ji Y, Chen S, Xu C, Li L, Xiang B . The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol. 2014; 172(1):24-32. DOI: 10.1111/bjd.13388. View

Li P, Guo Z, Gao Y, Pan W . Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner. Oncol Rep. 2015; 33(6):3099-107. DOI: 10.3892/or.2015.3911. View

Li W, Teng P, Xu H, Ma L, Ni Y . Cardiac Hemangioma: A Comprehensive Analysis of 200 Cases. Ann Thorac Surg. 2015; 99(6):2246-52. DOI: 10.1016/j.athoracsur.2015.02.064. View

10.

Darrow D, Greene A, Mancini A, Nopper A . Diagnosis and Management of Infantile Hemangioma. Pediatrics. 2015; 136(4):e1060-104. DOI: 10.1542/peds.2015-2485. View

11.

Tang L, Hing J, Tang J, Nishikawa H, Shahidullah H, Browne F . Predicting complications with pretreatment testing in infantile haemangioma treated with oral propranolol. Br J Ophthalmol. 2015; 100(7):902-906. DOI: 10.1136/bjophthalmol-2015-307284. View

12.

Shah S, Baselga E, McCuaig C, Pope E, Coulie J, Boon L . Rebound Growth of Infantile Hemangiomas After Propranolol Therapy. Pediatrics. 2016; 137(4). DOI: 10.1542/peds.2015-1754. View

13.

Delmo Walter E, Javier M, Sander F, Hartmann B, Ekkernkamp A, Hetzer R . Primary Cardiac Tumors in Infants and Children: Surgical Strategy and Long-Term Outcome. Ann Thorac Surg. 2016; 102(6):2062-2069. DOI: 10.1016/j.athoracsur.2016.04.057. View

14.

Petrovic J, Trifunovic B, Vukomanovic G, Topalovic M, Trajkovic G, Parezanovic V . Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment. J Dermatolog Treat. 2017; 28(6):554-558. DOI: 10.1080/09546634.2016.1277177. View

15.

Wnek A, Andrzejewska E, Kobos J, Taran K, Przewratil P . Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment. Immunol Lett. 2017; 185:27-31. DOI: 10.1016/j.imlet.2017.03.005. View

16.

Kim K, Choi T, Choi Y, Park Y, Hong K, Kim D . Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial. JAMA Dermatol. 2017; 153(6):529-536. PMC: 5817616. DOI: 10.1001/jamadermatol.2017.0250. View

17.

Mizutani K, Umaoka A, Tsuda K, Kakeda M, Habe K, Yamanaka K . Successful combination therapy of propranolol and prednisolone for a case with congenital Kasabach-Merritt syndrome. J Dermatol. 2017; 44(12):1389-1391. DOI: 10.1111/1346-8138.13984. View

18.

Rotter A, Oliveira Z . Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. J Dtsch Dermatol Ges. 2017; 15(12):1185-1190. DOI: 10.1111/ddg.13365. View

19.

Hagen R, Ghareeb E, Jalali O, Zinn Z . Infantile hemangiomas: what have we learned from propranolol?. Curr Opin Pediatr. 2018; 30(4):499-504. DOI: 10.1097/MOP.0000000000000650. View

20.

NADAS A, Ellison R . Cardiac tumors in infancy. Am J Cardiol. 1968; 21(3):363-6. DOI: 10.1016/0002-9149(68)90140-9. View